|
0
Votes
vote
Halt Medical receives $15M financing for commercialization of Acessa uterine fibroid treatment systemHalt Medical, Inc. announced today that it has received $15 million of financing to support commercialization of the Acessa System, a newly FDA cleared medical device to treat uterine fibroids. ... |

